株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

米国のペット用医薬品:第4版

Pet Medications in the U.S. - 4th Edition

発行 Packaged Facts 商品コード 217051
出版日 ページ情報 英文 159 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.81円で換算しております。
Back to Top
米国のペット用医薬品:第4版 Pet Medications in the U.S. - 4th Edition
出版日: 2015年10月16日 ページ情報: 英文 159 Pages
概要

米国におけるペット用医薬品の売上規模は、2015年に70億米ドル、2019年までに90億米ドルに達すると予測されています。

当レポートでは、米国のペット用医薬品市場について調査し、市場の動向と将来的成長見通し、小売り動向、消費者動向などについて分析しています。

第1章 エグゼクティブサマリー

第2章 市場動向

  • 市場規模と構成
  • 米国のペット用医薬品小売販売は2015年に70億米ドルに
  • 動物別売上シェア
  • 流通チャネル別売上シェア
  • 市場の見通し
  • 獣医市場
  • 将来の展望
  • 市場成長予測:売上は2019年までに90億米ドルに、ほか

第3章 マーケター

  • 競合概要
  • 処方薬・非処方薬マーケター
  • 小売りペット用医薬品マーケター
  • 注目の契約
  • 動物医療の新興企業の波
  • 抗寄生虫薬の世界
  • OTCブランド薬はマスチャネルで苦戦
  • 小売りノミ/ダニブランドへの注力
  • 広告・プロモーションにおける動向
  • 犬糸状虫市場における変化
  • 開発途上の市場セグメント動向
  • 脳の健康
  • 疼痛管理
  • 糖尿病
  • 心臓の健康
  • 耳感染症
  • 皮膚アレルギー、ほか

第4章 小売り動向

  • オムニチャネル消費者の課題
  • ペット所有者におけるペット用医薬品の利用とチャネルの選択
  • オンライン小売りは細分化
  • Vet-VIPPSは独占分野を示す
  • オンライン動物用薬局
  • マスマーケットの小売り業者はペット用医薬品に注力
  • モバイル獣医サービスの出現
  • ノミ・ダニはペット専門チャネルにとって重要、ほか

第5章 消費者動向

  • ペット用医薬品の購買形態
  • ノミ・ダニブランドの統計
  • 犬所有世帯の68%が犬糸状虫薬を使
  • ペット用医薬品に対する心理学的特徴
  • 獣医/専門家 vs. 店舗製品に対する姿勢
  • ペット用医薬品に対する抵抗と代替品、ほか

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: LA5416197

The market for pet medications in the U.S. has entered a period of redefinition and renewal. Merial's Frontline Plus is still the market leader in flea and tick medication, but it has a number of copycat competitors, selling at far less than the now off-patent powerhouse. But Merial has managed to not only stem the losses, but also gain back share via a new flea and tick blockbuster, Nexgard. In other areas, Zoetis introduced a blockbuster of its own, the anti-itch drug APOQUEL, and has had trouble meeting demand. The industry has also enjoyed the entrance of a wave of animal health start-ups, and a number of new drugs appear to be on the horizon.

Long sold primarily in the veterinary clinic, pet medications can be found in a variety of channels. Still, many animal health companies sell exclusively to the veterinary channel, which has drawn scrutiny from the FTC.

The pet medication space has also seen considerable investment action, from the position taken in Zoetis by the hedge fund of activist investor William Ackman to the sale of Novartis Animal Health's assets to Elanco and Virbac.

In its fourth edition, Pet Medications in the U.S. analyzes the market for prescription and over-the-counter medications for dogs and cats, with a particular focus on brand-name products used by consumers and on antiparasitics. Areas covered include parasite prevention and control (flea, tick, heartworm, etc.), cancer, pain management, behavioral health, diabetes, cognitive dysfunction, heart health, ear care and allergies. The report provides in-depth coverage of competitive trends, new product trends and marketing activity, and draws on insights from other reports in Packaged Facts' extensive Pet Market Collection. Statistics provided include historical and projected market revenues, along with demographics and psychographics of pet med purchasers, based on data from sources including Simmons and Packaged Facts own pet owner surveys.

Scope

This report examines the consumer market for medications for dogs and cats, with a focus on products used by consumers. These include prescription, over-the-counter (aka "retail"), and ethical products (nonprescription medications whose distribution is restricted by the manufacturer to veterinarians). The primary focus of this report is on antiparasitics (flea, tick, heartworm, etc.), but it also covers market-shaping developments in other areas including cancer, cognitive dysfunction, mood disorder, pain management, and obesity/diabetes.Animal health products for production animals and horses are excluded from this market analysis, as are nutritional supplements for horses and companion animals, the latter of which are covered in Packaged Facts' February 2015 report, Pet Supplements in the U.S., 5th Edition.

Report Methodology

The information contained in this report was obtained from primary and secondary research. Primary research entailed informal interviews with leading manufacturers of pet medications and with other pet industry experts; attendance at the Global Pet Expo and Petfood Forum trade events from 2005 through 2015; consultations with pet product manufacturers and members of the trade; and an on-site examination of retail venues. Secondary research included extensive Internet canvassing and research- and data-gathering from relevant consumer business and trade publications; company reports including annual reports, press releases, and investor conference calls; company profiles in trade and consumer publications; government reports; and other pet market reports by Packaged Facts.

Sales estimates are based on published and estimated sales of major market participants; market size estimates from other sources appearing in the trade press; figures obtained through consultation with market participants; the performance of relevant retail venues; consumer usage rates for pet medications; rates of company and product entries into the market; and sales data from IRI for multi-outlet (MULO), which represents sales through U.S. supermarkets, drugstores, mass merchandisers (Walmart, Target, Kmart, and Shopko), Sam's Club and BJ's warehouse clubs, dollar stores excluding Dollar Tree, and military commissaries.

Our consumer analysis draws primarily on two sources:

  • Simmons National Consumer Surveys from Experian Marketing Services. On an ongoing basis, Experian Marketing Services conducts booklet-based surveys of a large and random sample of consumers (approximately 25,000 for each 12-month survey compilation) who in aggregate represent a statistically accurate cross-section of the U.S. population.

Packaged Facts Pet Owner Surveys, including one conducted in August 2015. These surveys had a sample of 2,000 U.S. respondents age 18 or over who in aggregate are Census representative on the primary demographic measures of gender, age bracket, race/ethnicity, geographic region, household income bracket, and presence of children in the household.

Table of Contents

Chapter 1: Executive Summary

  • Scope and Methodology
  • Market Definition
    • Product Regulation
  • Report Methodology
  • Market Trends
  • Market Size & Composition
  • U.S. Retail Sales of Pet Medications at $7 Billion in 2015
  • Share of Sales by Distribution Channel
    • Figure 1-1 Share of U.S. Retail Sales of Pet Medications by Distribution Channel, 2015 (percent)
  • Market Outlook
    • Table 1-1 Projected U.S. Retail Sales of Pet Medications, 2015-2019(in billions of dollars)
  • Competitive Overview
  • Prescription and Non-prescription Marketers
  • Shakeup in the Global Animal Health Rankings
    • Table 1-2 Global Pharmaceutical Marketers: Total Sales vs. Animal Health Sales, 2013-2014 (in millions of dollars)
  • Retail Pet Medication Marketers
  • Notable Deals
    • AmerisourceBergen Snaps Up MWI Veterinary Supply
    • VCA Buys Camp Bow Wow
    • Novartis Assets Divvied Up
    • Parnell Pharmaceuticals Goes Public
    • Jaguar Animal Health Runs to Public Markets
  • Merial Wards Off the Competition
  • Retail Trends
  • The Challenge of the Omnichannel Consumer
  • FTC Reports Examines Competition in Industry
  • Consumer Trends
  • Three-Quarters of Dog or Cat Households Use Flea/Tick Products
  • Pet Owners Still Favor Spot-On Flea/Tick Medications
  • 68% of Dog-Owning Households Use Heartworm Meds
    • Figure 1-2 Purchasing of Heartworm Medications by Channel, 2015(U.S. dog owners)
  • Antibiotics Top List of Other Pet Medications
  • Attitudes on Veterinarian/Professional vs. Store Products
    • Table 1-3 Levels of Agreement/Disagreement with Statement,"I Trust the Pet Medications My Veterinarian Recommends":Dog Owners vs. Cat Owners, 2015 (percent)

Chapter 2: Market Trends

  • Market Size & Composition
  • U.S. Retail Sales of Pet Medications at $7 Billion in 2015
    • Table 2-1 U.S. Retail Sales of Pet Medications, 2011-2015(in billions of dollars)
  • Share of Sales by Animal Type
    • Figure 2-1 Share of U.S. Retail Sales of Pet Medications by Animal Type: Dog vs. Cat, 2015 (percent)
  • Share of Sales by Distribution Channel
    • Figure 2-2 Share of U.S. Retail Sales of Pet Medications by Distribution Channel, 2015 (percent)
    • Table 2-2 Share of U.S. Sales of Pet Medications by Type, 2015(percent)
  • Market Outlook
  • The Veterinary Market
  • Industry Banks on Higher-Income Households
    • Figure 2-3 $70K+ Household Share of U.S. Pet Market Expenditures: By Category, 2003 vs. 2013 (percent)
  • Pets Are No Spring Chickens
    • Table 2-3 Age of Dogs and Cats, 2015 (percent of pet owners)
    • Figure 2-4 Percentage of Dogs and Cats Age 6 and Over, 1987 vs. 2011 (percent)
  • Overweight Pets at Risk
    • Table 2-4 Agreement With Statement: "I have an overweight dog/cat," 2014 vs. 2015 (percent)
  • Morris Animal Foundation a Primary Research Funder
  • IBM's Watson to Advise Veterinarians
  • Pet Insurance Making Strides
    • Figure 2-5 Projected North American Pet Insurance Market Revenues: United States, Canada, and North America, 2013 vs. 2018 (in millions of U.S. dollars)
  • Optimism in Economy Increases, But Consumers Still Wary
  • Some Consumers Still Spending Less
    • Table 2-5 Level of Agreement with Statement: "I am spending less on pet products because of the economy," 2010-2015 (percent)
    • Table 2-6 Economic Mood of U.S. Pet Households, 2011-2015 (percent)
    • Table 2-7 Economic Outlook of U.S. Pet Households, 2011-2015 (percent)
  • Veterinary Visit Statistics
    • Table 2-8 Percentage of Dog and Cat Owners Who Have Visited Vet in Past Year: Routine Checkup vs. Sick/Emergency Care, 2015 (percent)
  • Veterinary Prices Rising or Falling?
  • Industry Attempts to Reverse Trend
  • Updates on Bayer Veterinary Care Usage Study
  • Veterinarians a Key Source for Parasite Prevalence
  • Information
  • Holistic and Natural Treatments
    • Table 2-9 Use of Specialty Nutritional Formula Pet Food, Treats, and Pet Supplements, Last 30 Days: Dog Owners vs. Cat Owners, 2015 (percent)
  • Looking Ahead
  • Projected Market Growth: Sales to Close in on $9 Billion by 2019
    • Table 2-10 Projected U.S. Retail Sales of Pet Medications, 2015-2019 (in billions of dollars)

Chapter 3: The Marketers

  • Competitive Overview
  • Prescription and Non-prescription Marketers
  • Shakeup in the Global Animal Health Rankings
    • Table 3-1 Global Pharmaceutical Marketers: Total Sales vs. Animal Health Sales, 2013-2014 (in millions of dollars)
    • Table 3-2 Global Pharmaceutical Marketers by Dollar and Percentage Change in Global Sales: Total vs. Animal Health, 2013-2014 (in millions of dollars)
    • Table 3-3 Global Pharmaceutical Marketers by Dollar and Percentage Change in Global Sales: Animal Health, 2015 (projected) (in millions of dollars)
  • Retail Pet Medication Marketers
  • Notable Deals
    • AmerisourceBergen Snaps Up MWI Veterinary Supply
    • VCA Buys Camp Bow Wow
    • PetSmart Makes a Web Play
    • Petco Increases Pet Health Reach with Drs. Foster & Smith Purchase
    • Petco Files for IPO
    • Novartis Assets Divided Up
    • Interest in Zoetis
    • Parnell Pharmaceuticals Goes Public
    • Jaguar Animal Health Runs to Public Markets
    • Veterinary Practice Businesses Change Owners
    • H.I.G. Capital Creates Community Veterinary Clinics, LLC
    • Shore Capital Jumps into Veterinary Market
    • More Veterinary Practices Consolidate
  • Wave of Animal Health Startups
  • Generics Still Trying to Make In-Roads
    • Generics Continue Assault of the Frontline Franchise
    • Putney Keeps the Generics Coming
    • Illustration 3-1 Trade Ad for Putney's Carprofen Chewable Tablets
    • Putney Surveys Veterinarians About Generics
    • Norbrook Also a Generics Player
    • Illustration 3-2 Trade Ad for Norbrook's Carprieve Injection
  • The World of Antiparasitics
  • Merial Still Tops the Flea/Tick Charts
    • Table 3-4 Marketer Shares of U.S. Flea & Tick Sales, 2015 (percent)
  • Merial Wards Off the Competition
    • Illustration 3-3 Screenshot from Frontline Plus Commercial
  • Bayer's Lineup Packs a Punch
    • Advantage's History in the Trade
  • Zoetis Eyes a Bigger Slice of Parasiticide Market
  • Elanco's Growth
  • Virbac Adds to U.S. Offerings
  • Ceva Picks Up Growth
    • Merck Adds Chewable to Product Line
    • Illustration 3-4 Trade Ad Introducing Merck's Bravecto
  • OTC Brands Struggle in Mass Channels
    • Table 3-5 IRI-tracked Sales of Pet Medications, 2015
    • Table 3-5 [cont'd] IRI-tracked Sales of Pet Medications, 2015
    • Table 3-5 [cont'd] IRI-tracked Sales of Pet Medications, 2015
  • Focus on Retail Flea/Tick Brands
    • Central Garden & Pet Performance
    • Illustration 3-5 Screen shot of Bio Spot Active Care website
    • Hartz Campaign Focuses on Year-Round Protection
    • Perrigo Launches Frontline Plus Versions
    • Illustration 3-6 Screenshot of PetArmor's Website Touting PetArmor Plus
    • Other Frontline Plus Copycats Emerge
    • Illustration 3-7 Screenshot of PetAction Plus Ad
    • Illustration 3-8 Screenshots of PetArmor Plus Ad
    • Illustration 3-9 Spectra Sure Floor Display
  • Trends in Advertising and Promotion
    • Bayer
    • Illustration 3-10 Bayer's K9s For Warriors Campaign
    • Illustration 3-11 Banner Ad for Seresto
    • Perrigo
    • Central Garden & Pet
    • Illustration 3-12 Adams Smart Pets Contest
    • Ceva Animal Health
    • Illustration 3-13 Screen Shot from Vectra 3D Video
    • Elanco
    • Illustration 3-14 Screenshot of Elanco's Celebrate the Bond Website
    • Hartz
    • Merial
    • Illustration 3-15 Buzzfeed Channel for Frontline Plus
    • Illustration 3-16 Screen shot from NexGard "Doggone Funny" Video
  • Changes in Heartworm Market
  • Virbac Joins Big Leagues
  • Elanco Brings Back Interceptor
    • Illustration 3-17 Trade Ad for Interceptor
  • Heartgard Keeps Rolling
  • Heartworm Advertising and Promotion
    • Illustration 3-18 Screen shot for Merial's IHeartgardMyDog.com
    • Illustration 3-19 Two-page trade ad for Virbac's Heartworm Products
  • Broad Spectrum Wormers
    • Illustration 3-20 Trade Ad for Profender
  • Trends in Developing Market Segments
  • Cancer
  • Brain Health
  • Pain Management
    • Major Brands
    • Illustration 3-21 Banner Ad for Bayer's Quellin (Carprofen)
    • Illustration 3-22 Trade Ad for Metacam
    • Illustration 3-23 Trade Ad for Merial's Previcox
    • Illustration 3-24 Banner Ad for the Rimadyl K9 Courage Program
    • Illustration 3-25 Trade Ad for Simbadol
  • Diabetes
    • Illustration 3-26 Trade Ad for Vetsulin
  • Heart Health
    • Illustration 3-27 Trade Ad for Boehringer Ingelheim Vetmedica's Vetmedin
  • Ear Infections
    • Illustration 3-28 Trade Ad for Merial's Tresaderm
    • Illustration 3-29 Trade Ad for Elanco Earnings Mentioning Surolan
  • Skin Allergies
    • Illustration 3-30 Banner Ad for Convenia's My Pet Itches Website
    • Illustration 3-31 Atopica for Cats Website

Chapter 4: Retail Trends

  • The Challenge of the Omnichannel Consumer
  • FTC Reports Examines Competition in Industry
  • Pet Meds Use and Channel Choices Among Pet Adopters
  • Online Retail Appears Fragmented
    • Illustration 4-1 Newspaper Free-Standing Insert for PetCareRx.com
  • Vet-VIPPS Marks Exclusive Territory
  • Veterinary Pharmacies Online
    • Illustration 4-2 Vets First Choice Trade Ad
  • PetMed Express Sees Slow Growth
    • Illustration 4-3 Screenshot from 1-800-PetMeds' TV Commercial
    • Table 4-1 PetMed Express Sales, 2007-2015 (in millions of dollars)
  • PetSmart and Petco Step Up Web Game
    • Illustration 4-4 Banner on Petco.com Home Page Touting Doctors Foster and Smith
    • Illustration 4-5 Pet360 Information Page on PetSmart.com
  • Mass Market Retailers Emphasize Pet Meds
    • Illustration 4-6 Endcap of Pet Aisle at Sam's Club
  • Mobile Veterinary Services Popping Up
    • Illustration 4-7: Left: Vaccination Clinic Announcement in Front of Tractor Supply Company; Right: Vaccination Cooler at Tractor Supply Company
  • Fairness to Pet Owners Act Still on the Table
  • Flea & Tick Important to Pet Specialty Channel
    • Illustration 4-8 Screenshot from PetSmart Flea & Tick Ad
    • Illustration 4-9 Screenshot from Petco Ad Featuring Bayer and TruRx Products
    • Illustration 4-10 Flea & Tick Section from Pet Supplies Plus June-July 2015 Flyer
    • Illustration 4-11 Screenshot for Sentry Fiproguard Plus Ad

Chapter 5: Consumer Trends

  • Pet Medication Purchasing Patterns
  • Three-Quarters of Dog or Cat Households Use Flea/Tick Products .. 133
    • Table 5-1 Percent of Dog or Cat Owners Who Purchase Flea & Tick Care Medications or Medicated Products, 2012-2015 (U.S. dog- or cat-owning households in thousands)
  • Pet Owners Still Favor Spot-On Flea/Tick Medications
    • Figure 5-1 Purchasing of Flea & Tick Care Medications: Share by Product Type, 2015 (percent of U.S. dog or cat owners)
    • Figure 5-2 Purchasing of Spot-On Flea & Tick Care Medication by Channel, 2015 (U.S. dog or cat owners)
  • Frontline Still the Top Draw, But Brand Usage More Varied
    • Table 5-2 Share of Flea & Tick Care Medication Purchasers by Brand, 2015 (U.S. dog owners)
    • Table 5-3 Share of Flea & Tick Care Topical Medication Purchasers by Brand, 2015 (U.S. cat owners)
  • Demographics for Flea & Tick Brands
    • Table 5-4a Index for Use of Flea/Tick Products by Brand, 2015
    • Table 5-4a [Cont.] Index for Use of Flea/Tick Products by Brand, 2015 (U.S. dog- or cat-owning households)
    • Table 5-4a [Cont.] Index for Use of Flea/Tick Products by Brand, 2015 (U.S. dog- or cat-owning households)
    • Table 5-4b Index for Use of Flea/Tick Products by Brand, 2015
    • Table 5-4b [cont'd] Index for Use of Flea/Tick Products by Brand, 2015
    • Table 5-4b [cont'd] Index for Use of Flea/Tick Products by Brand, 2015
  • 68% of Dog-Owning Households Use Heartworm Meds
    • Table 5-5 Index for Use of Heartworm Control Medications for Dogs, 2015
    • Table 5-5 [cont'd] Index for Use of Heartworm Control Medications for Dogs, 2015
    • Table 5-5 [cont'd] Index for Use of Heartworm Control Medications for Dogs, 2015
    • Figure 5-3 Purchasing of Heartworm Medications by Channel, 2015 (U.S. dog owners)
  • Dog Owners Prefer Heartgard
    • Table 5-6 Share of Heartworm Purchasers by Brand, 2015 (U.S. dog owners)
  • Antibiotics Top List of Other Pet Medications
    • Table 5-7 Use by Type of Selected Other Pet Medications for Dogs and Cats, 2015 (percent)
    • Table 5-8 Purchasing by Channel of Selected Other Pet Medications for Dogs, 2015 (percent)
    • Table 5-9 Purchasing by Channel of Selected Other Pet Medications for Cats, 2015 (percent)
  • For Flea/Tick, Veterinarians and Walmart Key for Dog Owners
    • Table 5-10 Purchasing of Flea/Tick Care Medications by Channel: Dog Owners, 2015 (percent)
  • Internet Favorites Differ By Prescription and Non- Prescription
    • Table 5-11 Purchasing of Prescription Dog and Cat Medications by Online Source, 2015 (percent)
    • Table 5-12 Purchasing of Non-Prescription Dog and Cat Medications by Online Source, 2015 (percent)
  • Pet Med Psychographics
  • Pet Owners Keep Pet Med Purchases Consistent
    • Table 5-13 Levels of Agreement/Disagreement with Statement, "I Am Buying More Pet Medications Than I Used To": Dog Owners vs. Cat Owners, 2015 (percent)
    • Table 5-14 Levels of Agreement/Disagreement with Statement "The Current Range of Pet Medications Is Not Adequate": Dog Owners vs. Cat Owners, 2015 (percent)
    • Table 5-15 Levels of Agreement/Disagreement with Statement, "I Am Interested in New Types of Pet Medications": Dog Owners vs. Cat Owners, 2015 (percent)
  • Pet Owners See Age- and Weight-Related Causes
    • Table 5-16 Levels of Agreement/Disagreement with Statement, "Age-Related Conditions Are the Cause of Some of the Pet Medications That I Buy": Dog Owners vs. Cat Owners, 2015 (percent)
    • Table 5-17 Levels of Agreement/Disagreement with Statement, "Weight/Obesity-Related Conditions Are the Cause of Some of the Pet Medications That I Buy": Dog Owners vs. Cat Owners, 2015 (percent)
  • Attitudes on Veterinarian/Professional vs. Store Products
    • Table 5-18 Levels of Agreement/Disagreement with Statement, "I Trust the Pet Medications My Veterinarian Recommends": Dog Owners vs. Cat Owners, 2015 (percent)
    • Table 5-19 Levels of Agreement/Disagreement with Statement, "I Trust the Pet Medications Available at the Stores Where I Buy Pet Products": Dog Owners vs. Cat Owners, 2015 (percent)
    • Table 5-20 Levels of Agreement/Disagreement with Statement, "With Spot-On (Topical) Flea/Tick Products, the Products Available in Stores Are Just as Effective as Those Available Through Veterinarians": Dog Owners vs. Cat Owners, 2015 (percent)
    • Table 5-21 Levels of Agreement/Disagreement with Statement, "With Spot-On (Topical) Flea/Tick Products, I Would Trust Generic or Store-Brand Products if They Contained the Same Active Ingredients": Dog Owners vs. Cat Owners, 2015 (percent)
    • Table 5-22 Levels of Agreement/Disagreement with Statement, "Veterinarian-Dispensed Spot-On (Topical) Flea/Tick Products Are Too Expensive": Dog Owners vs. Cat Owners, 2015 (percent)
  • Resistance and Alternatives to Pet Meds
    • Table 5-23 Levels of Agreement/Disagreement with Statement, "I Avoid Using Pet Medications as Much as Possible": Dog Owners vs. Cat Owners, 2015 (percent)
    • Table 5-24 Levels of Agreement/Disagreement with Statement, "I Prefer to Try Holistic/Natural Pet Treatments Including Nutritional Supplements Before Resorting to Pet Medications": Dog Owners vs. Cat Owners, 2015 (percent)
    • Table 5-25 Levels of Agreement/Disagreement with Statement, "High-Quality Pet Foods Are Effective as a Preventive Pet Health Treatment": Dog Owners vs. Cat Owners, 2015 (percent)
Back to Top